Avycaz Powder, For Solution
Product Images NDC 0456-2700
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Avycaz (NDC 0456-2700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 Chemical Structure Of Avibactam Sodium (Avycaz 02)
Principal Display Panel (Carton NDC 0456-2700-01 Rx onlyAvycaz® 2.5 g per vial* (ceftazidime and avibactam) for injection *Ceftazidime 2 gram (equivalent to 2.635 g ceftazidime pentahydrate/sodium carbonate) and avibactam 0.5 g (equivalent to 0.551 g avibactam sodium). MUST BE CONSTITUED THEN DILUTED. FOR INTRAVENUS INFUSION.)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.